Targeting a host receptor instead of the virus: a new experimental approach against hepatitis C virus.
24.03.2015 - Press release
(Français) Une collaboration internationale conduite par le Professeur Thomas Baumert met en évidence qu’un anticorps monoclonal spécifiquement dirigé contre la claudine-1, permet de prévenir et de traiter une infection chronique par ce virus dans un modèle animal. ...
Predicting the end of fertility for women after paediatric cancer
23.03.2015 - Press release
Researchers from the Paris Public Hospitals (AP-HP), Inserm, the Gustave Roussy and Curie Institutes, and Oscar Lambret Cancer Centre, coordinated by Dr Cécile Thomas-Teinturier of the Paediatric Endocrinology Service at Bicêtre Hospital, have studied the impact of certain therapeutic agents on the ...
Anne Dejean-Assémat, is awarded the Inserm Grand Prix for 2014
26.11.2014 - Press release
The Inserm Grand Prix is awarded to Anne Dejean-Assémat, director of Inserm/Institut Pasteur Joint Unit 993 “Nuclear Organization and Oncogenesis,” for her entire body of research on the molecular and cellular mechanisms involved in the development of human cancers. ...
Lung cancer diagnosed before it is detected by imaging
31.10.2014 - Press release
A team of researchers from Inserm led by Paul Hofman (Inserm Unit 1081/University of Nice) has just made a significant advance in the area of early diagnosis of invasive cancers. ...
Colon cancer: Two genetic alterations that generate metastases
09.10.2014 - Press release
With approximately 42,000 estimated new cases in France in 2012, colon cancer is, for both sexes combined, the third most common type of cancer, and the second most common cause of cancer deaths after lung cancer. ...
New resistance mechanisms to melanoma targeted therapies : contribution of the translation of RNAs into proteins
28.07.2014 - Press release
French investigators have discovered new resistance mechanisms to targeted therapies used for less than three years in the treatment of melanoma. This discovery enables us not only to better understand why these treatments become ineffective but also to reveal new avenues for ...